Thompson, AJ;
Zaratin, P;
Comi, G;
Coetzee, T;
Ramsey, K;
Panzara, M;
(2016)
Progressive MS Alliance Industry Forum: maximizing collective impact to enable drug development.
Trends in Pharmacological Sciences
, 37
(10)
pp. 808-810.
10.1016/j.tips.2016.07.005.
Preview |
Text
Thompson_1-s2.0-S0165614716300943REDACTED.pdf - Published Version Download (156kB) | Preview |
Abstract
The Progressive MS Alliance Industry Forum describes a new approach to address barriers to developing treatments for progressive multiple sclerosis (MS). This innovative model promises to facilitate robust collaboration between industry, academia, and patient organizations and accelerate research towards the overarching goal of developing safe and effective treatments for progressive MS.
| Type: | Article |
|---|---|
| Title: | Progressive MS Alliance Industry Forum: maximizing collective impact to enable drug development |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.tips.2016.07.005 |
| Publisher version: | http://dx.doi.org/10.1016/j.tips.2016.07.005 |
| Language: | English |
| Additional information: | Copyright © 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the Creative Commons Attribution 4.0 International (CC BY 4.0) license (http://creativecommons.org/licenses/by/4.0/) |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1507780 |
Archive Staff Only
 |
View Item |
